Gut Microbiota and Metabolic Specificity in Ulcerative Colitis and Crohn's Disease
- PMID: 33330572
- PMCID: PMC7729129
- DOI: 10.3389/fmed.2020.606298
Gut Microbiota and Metabolic Specificity in Ulcerative Colitis and Crohn's Disease
Abstract
Background: Inflammatory bowel disease (IBD) represents multifactorial chronic inflammatory conditions in the gastrointestinal tract and includes Crohn's disease (CD) and ulcerative colitis (UC). Despite similarities in pathobiology and disease symptoms, UC and CD represent distinct diseases and exhibit diverse therapeutic responses. While studies have now confirmed that IBD is associated with dramatic changes in the gut microbiota, specific changes in the gut microbiome and associated metabolic effects on the host due to CD and UC are less well-understood. Methods: To address this knowledge gap, we performed an extensive unbiased meta-analysis of the gut microbiome data from five different IBD patient cohorts from five different countries using QIIME2, DIAMOND, and STAMP bioinformatics platforms. In-silico profiling of the metabolic pathways and community metabolic modeling were carried out to identify disease-specific association of the metabolic fluxes and signaling pathways. Results: Our results demonstrated a highly conserved gut microbiota community between healthy individuals and IBD patients at higher phylogenetic levels. However, at or below the order level in the taxonomic rank, we found significant disease-specific alterations. Similarly, we identified differential enrichment of the metabolic pathways in CD and UC, which included enriched pathways related to amino acid and glycan biosynthesis and metabolism, in addition to other metabolic pathways. Conclusions: In conclusion, this study highlights the prospects of harnessing the gut microbiota to improve understanding of the etiology of CD and UC and to develop novel prognostic, and therapeutic approaches.
Keywords: Crohn's disease; gut microbiome; metabolism; prognosis; ulcerative colitis.
Copyright © 2020 Sankarasubramanian, Ahmad, Avuthu, Singh and Guda.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
Similar articles
-
Functional Characterization of Inflammatory Bowel Disease-Associated Gut Dysbiosis in Gnotobiotic Mice.Cell Mol Gastroenterol Hepatol. 2016 Mar 3;2(4):468-481. doi: 10.1016/j.jcmgh.2016.02.003. eCollection 2016 Jul. Cell Mol Gastroenterol Hepatol. 2016. PMID: 27795980 Free PMC article.
-
Overrepresentation of Enterobacteriaceae and Escherichia coli is the major gut microbiome signature in Crohn's disease and ulcerative colitis; a comprehensive metagenomic analysis of IBDMDB datasets.Front Cell Infect Microbiol. 2022 Oct 4;12:1015890. doi: 10.3389/fcimb.2022.1015890. eCollection 2022. Front Cell Infect Microbiol. 2022. PMID: 36268225 Free PMC article.
-
Dysbiosis and Ecotypes of the Salivary Microbiome Associated With Inflammatory Bowel Diseases and the Assistance in Diagnosis of Diseases Using Oral Bacterial Profiles.Front Microbiol. 2018 May 30;9:1136. doi: 10.3389/fmicb.2018.01136. eCollection 2018. Front Microbiol. 2018. PMID: 29899737 Free PMC article.
-
Alteration of Gut Microbiota in Inflammatory Bowel Disease (IBD): Cause or Consequence? IBD Treatment Targeting the Gut Microbiome.Pathogens. 2019 Aug 13;8(3):126. doi: 10.3390/pathogens8030126. Pathogens. 2019. PMID: 31412603 Free PMC article. Review.
-
Inflammatory bowel disease: between genetics and microbiota.Mol Biol Rep. 2020 Apr;47(4):3053-3063. doi: 10.1007/s11033-020-05318-5. Epub 2020 Feb 21. Mol Biol Rep. 2020. PMID: 32086718 Review.
Cited by
-
Differences in bacterial taxa between treatment-naive patients with major depressive disorder and non-affected controls may be related to a proinflammatory profile.BMC Psychiatry. 2024 Jan 31;24(1):84. doi: 10.1186/s12888-024-05547-z. BMC Psychiatry. 2024. PMID: 38297265 Free PMC article.
-
Evaluation of gut microbiota predictive potential associated with phenotypic characteristics to identify multifactorial diseases.Gut Microbes. 2024 Jan-Dec;16(1):2297815. doi: 10.1080/19490976.2023.2297815. Epub 2024 Jan 18. Gut Microbes. 2024. PMID: 38235595 Free PMC article.
-
Gut microbiota signatures in inflammatory bowel disease.United European Gastroenterol J. 2024 Feb;12(1):22-33. doi: 10.1002/ueg2.12485. Epub 2023 Dec 2. United European Gastroenterol J. 2024. PMID: 38041519 Free PMC article.
-
Effect of minocycline, methyl prednisolone, or combination treatment on the colonic bacterial population in a state of colonic inflammation using the murine dextran sulfate sodium model.Microb Cell Fact. 2023 Nov 10;22(1):232. doi: 10.1186/s12934-023-02242-8. Microb Cell Fact. 2023. PMID: 37950185 Free PMC article.
-
Profiling the inflammatory bowel diseases using genetics, serum biomarkers, and smoking information.iScience. 2023 Sep 26;26(10):108053. doi: 10.1016/j.isci.2023.108053. eCollection 2023 Oct 20. iScience. 2023. PMID: 37841595 Free PMC article.
References
Publication types
Associated data
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous
